SCHEMBL7416308

SCHEMBL7416308

CCN(CC)CCn1c(=O)c(C(=O)O)nc2ccccc21

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.60
CYP2C9 P11712 2/20 0.59
CYP2C19 P33261 2/20 0.59
USP2 O75604 1/20 0.59
CYP1A2 P05177 1/20 0.59
GLA P06280 1/20 0.59
CYP2D6 P10635 1/20 0.59
NPSR1 Q6W5P4 1/20 0.59
PKM P14618 1/20 0.59
MAPK1 P28482 1/20 0.59
CASP1 P29466 1/20 0.59
CASP7 P55210 1/20 0.59
HTT P42858 3/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
MAPT P10636 2/20 0.58
CYP3A4 P08684 1/20 0.58
TOP2A P11388 1/20 0.58
OPRK1 P41145 2/20 0.55
DRD3 P35462 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8861179 0.85 ALDH1A1 (0.70) ALDH1A1CYP2C9CYP2C19USP2CYP1A2
SCHEMBL5717623 0.81 ALDH1A1 (0.67) ALDH1A1CYP2C9CYP2C19CYP1A2GLA
SCHEMBL1966502 0.81 PKM (0.64) ALDH1A1USP2NPSR1PKMHTT
SCHEMBL9103612 0.78 MAPK1 (0.62) ALDH1A1CYP2C9CYP2C19CYP1A2GLA
SCHEMBL9107325 0.77 MAPK1 (0.61) ALDH1A1CYP2C9CYP2C19CYP1A2GLA
SCHEMBL1963729 0.77 CFTR (0.57) ALDH1A1PKMTOP2AOPRK1DRD3
SCHEMBL6579407 0.76 CFTR (0.63) ALDH1A1CYP2C9CYP2C19CYP1A2GLA
SCHEMBL3881848 0.75 MLNR (0.77) ALDH1A1USP2PKMMAPK1HTT
SCHEMBL2783065 0.75 ALDH1A1 (0.59) ALDH1A1CYP2C9CYP2C19CYP1A2GLA
SCHEMBL29724622 0.75 ALDH1A1 (0.59) ALDH1A1CYP2C9CYP2C19CYP1A2GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1087768-A1 USE OF 1-(AMINOALKYL)-3-QUINOXALINE-2-ONE DERIVATIVES FOR THE PREPARATION OF COMPOUNDS HAVING AN ANTIOXIDANT ACTION PHAFAG AKTIENGESELLSCHAFT (LI) 2001-04-04 EP disclosed
WO-1999066931-A1 USE OF 1-(AMINOALKYL)-3-QUINOXALINE-2-ONE DERIVATIVES FOR THE PREPARATION OF COMPOUNDS HAVING AN ANTIOXIDANT ACTION PHAFAG AKTIENGESELLSCHAFT (LI) 1999-12-29 WO disclosed